Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: Results from the placement of aortic transcatheter valve trial

Circulation: Cardiovascular Interventions

Volumn 7, Issue 6, 2014, Pages 829-836

  Arnold, Suzanne V ^a,b   Lei, Yang ^a   Reynolds, Matthew R ^c   Magnuson, Elizabeth A ^a,b   Suri, Rakesh M ^d   Tuzcu, E Murat ^e   Petersen, John L ^f   Douglas, Pamela S ^g   Svensson, Lars G ^e   Gada, Hemal ^h   Thourani, Vinod H ⁱ   Kodali, Susheel K ^h   Mack, Michael J ^j   Leon, Martin B ^h   Cohen, David J ^a,b  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^d MAYO CLINIC   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f SWEDISH MEDICAL CENTER   (United States)

^g DUKE UNIVERSITY   (United States)

^h Department of Orthopaedic Surgery   (United States)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j Baylor Healthcare System   (United States)

more..

Author keywords

Aortic valve; Complications; Costs and cost analysis; Transcatheter aortic valve replacement

Indexed keywords

CREATININE;

AGED; AORTA STENOSIS; ARTICLE; ATRIOVENTRICULAR BLOCK; BLEEDING; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMPLICATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DISEASE SEVERITY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HOSPITAL COST; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; LENGTH OF STAY; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PACEMAKER IMPLANTATION; PATIENT HISTORY OF CORONARY ARTERY BYPASS GRAFT; PERIPHERAL VASCULAR DISEASE; PERIPROCEDURAL COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMORBIDITY; DEVICES; ECONOMIC MODEL; ECONOMICS; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HOSPITAL MORTALITY; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL COSTS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LENGTH OF STAY; LINEAR MODELS; LOGISTIC MODELS; MALE; MODELS, ECONOMIC; MULTIVARIATE ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84925854654     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.114.001395     Document Type: Article

References (18)

1. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363: 1597-607.
2. Reynolds MR, Magnuson EA, Lei Y, Leon MB, Smith CR, Svensson LG, Webb JG, Babaliaros VC, Bowers BS, Fearon WF, Herrmann HC, Kapadia S, Kodali SK, Makkar RR, Pichard AD, Cohen DJ. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation. 2011;124: 1964-1972.
3. Reynolds MR, Magnuson EA, Wang K, Lei Y, Vilain K, Walczak J, Kodali SK, Lasala JM, O'Neill WW, Davidson CJ, Smith CR, Leon MB, Cohen DJ. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: Results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation. 2012;125: 1102-1109.
4. Mack MJ, Brennan JM, Brindis R, Carroll J, Edwards F, Grover F, Shahian D, Tuzcu EM, Peterson ED, Rumsfeld JS, Hewitt K, Shewan C, Michaels J, Christensen B, Christian A, O'Brien S, Holmes D. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. 2013;310: 2069-2077.
5. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364: 2187-2198.
6. Reynolds MR, Magnuson EA, Lei Y, Wang K, Vilain K, Li H, Walczak J, Pinto DS, Thourani VH, Svensson LG, Mack MJ, Miller DC, Satler LE, Bavaria J, Smith CR, Leon MB, Cohen DJ. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: Results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol. 2012;60: 2683-2692.
7. Taira DA, Seto TB, Siegrist R, Cosgrove R, Berezin R, Cohen DJ. Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials. Am Heart J. 2003;145: 452-458.
8. Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: How good a basis for estimating costs? Inquiry. 1995;32: 476-481.
9. Simons CT, Cipriano LE, Shah RU, Garber AM, Owens DK, Hlatky MA. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: A cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes. 2013;6: 419-428.
10. Osnabrugge RL, Kappetein AP, Reynolds MR, Cohen DJ. Costeffectiveness of transcatheter valvular interventions: Economic challenges. EuroIntervention. 2013;9 suppl: S48-S54.
11. The Advisory Board. UPDATE: Recent CMS reimbursement coverage calls attention to TAVR financial picture. July 9, 2012.
12. Dewey TM, Bowers B, Thourani VH, Babaliaros V, Smith CR, Leon MB, Svensson LG, Tuzcu EM, Miller DC, Teirstein PS, Tyner J, Brown DL, Fontana GP, Makkar RR, Williams MR, George I, Kirtane AJ, Bavaria JE, Mack MJ. Transapical aortic valve replacement for severe aortic stenosis: Results from the nonrandomized continued access cohort of the PARTNER trial. Ann Thorac Surg. 2013;96: 2083-2089.
13. Toggweiler S, Gurvitch R, Leipsic J, Wood DA, Willson AB, Binder RK, Cheung A, Ye J, Webb JG. Percutaneous aortic valve replacement: Vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol. 2012;59: 113-118.
14. Genereux P, Webb JG, Svensson LG, Kodali SK, Satler LF, Fearon WF, Davidson CJ, Eisenhauer AC, Makkar RR, Bergman GW, Babaliaros V, Bavaria JE, Velazquez OC, Williams MR, Hueter I, Xu K, Leon MB. Vascular complications after transcatheter aortic valve replacement: Insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol. 2012;60: 1043-1052.
15. Généreux P, Kodali SK, Green P, Paradis JM, Daneault B, Rene G, Hueter I, Georges I, Kirtane A, Hahn RT, Smith C, Leon MB, Williams MR. Incidence and effect of acute kidney injury after transcatheter aortic valve replacement using the new valve academic research consortium criteria. Am J Cardiol. 2013;111: 100-105.
16. Gada H, Kapadia SR, Tuzcu EM, Svensson LG, Marwick TH. Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Cardiol. 2012;109: 1326-1333.
17. Gada H, Agarwal S, Marwick TH. Perspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: Outcomes of a decision-analytic model. Ann Cardiothorac Surg. 2012;1: 145-155.
18. Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized end point definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60: 1438-1454.